CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Stock option (right to buy) | +193,957 | 193,957 | ||
| 2026-09-15 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +193,957 | 193,957 | ||
| 2026-09-15 | Dugan Margaret Chief Medical Officer | Grant or award · Stock Option (right to buy) | +81,250 | 81,250 | ||
| 2026-09-15 | Dugan Margaret Chief Medical Officer | Grant or award · Restricted Stock Units | +81,250 | 81,250 | ||
| 2026-09-15 | Dornan David Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +85,887 | 85,887 | ||
| 2026-09-15 | Dornan David Chief Scientific Officer | Grant or award · Restricted Stock Units | +85,887 | 85,887 | ||
| 2026-09-15 | BALL BRYAN See remarks | Grant or award · Stock Option (right to buy) | +91,633 | 91,633 | ||
| 2026-09-15 | BALL BRYAN See remarks | Grant or award · Restricted Stock Units | +91,633 | 91,633 | ||
| 2026-09-15 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +118,476 | 118,476 | ||
| 2026-09-15 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +118,476 | 118,476 | ||
| 2026-09-15 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Stock option (right to buy) | +193,957 | 193,957 | ||
| 2026-09-15 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +193,957 | 193,957 | ||
| 2026-09-15 | Dugan Margaret Chief Medical Officer | Grant or award · Stock Option (right to buy) | +81,250 | 81,250 | ||
| 2026-09-15 | Dugan Margaret Chief Medical Officer | Grant or award · Restricted Stock Units | +81,250 | 81,250 | ||
| 2026-09-15 | Dornan David Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +85,887 | 85,887 | ||
| 2026-09-15 | Dornan David Chief Scientific Officer | Grant or award · Restricted Stock Units | +85,887 | 85,887 | ||
| 2026-09-15 | BALL BRYAN See remarks | Grant or award · Stock Option (right to buy) | +91,633 | 91,633 | ||
| 2026-09-15 | BALL BRYAN See remarks | Grant or award · Restricted Stock Units | +91,633 | 91,633 | ||
| 2026-09-15 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +118,476 | 118,476 | ||
| 2026-09-15 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +118,476 | 118,476 |
Page 1 of 9 · 171 trades